ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,607, issued on April 21, was assigned to Immunocore Ltd. (Abingdon, Great Britain). "T cell receptors" was invented by Conor Hayes (Abingd... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,608, issued on April 21, was assigned to Universitatsmedizin Der Johannes Gutenberg-Univeristat Mainz (Mainz, Germany). "Modified NK-92 ce... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,609, issued on April 21, was assigned to CHIESI FARMACEUTICI S.p.A. (Parma, Italy). "Polypeptides having improved properties" was invented... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,610, issued on April 21, was assigned to Azitra Inc (Branford, Conn.). "Compositions and methods for treatment of Netherton Syndrome with ... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,611, issued on April 21, was assigned to The United States of America as represented by the Secretary Department of Health & Human Services... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,612, issued on April 21, was assigned to The Wistar Institute of Anatomy and Biology (Philadelphia). "Multivalent DNA antibody constructs ... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,613, issued on April 21, was assigned to InflaRx GmbH (Jena, Germany). "Humanized anti-C5a antibodies" was invented by Renfeng Guo (Ann Ar... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,614, issued on April 21, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Human FcRn-binding modified antibodies and methods ... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,615, issued on April 21, was assigned to KYOWA KIRIN Co. LTD. (Tokyo). "Anti-FGF23 antibody or antibody fragment thereof" was invented by ... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,616, issued on April 21, was assigned to Cardiff Oncology Inc. (San Diego). "PLK1 inhibitor in combination with anti-angiogenics for treat... Read More